The Worldwide Minimally Invasive Surgical Instruments Industry is Expected to Reach $51.49 Billion by 2028

DUBLIN, Jan. 5, 2022 /PRNewswire/ -- The "Global Minimally Invasive Surgical Instruments Market Size, Share & Trends Analysis Report by Application (Orthopedic, Cosmetic), Device (Handheld Instruments, Electrosurgical Devices), End-use, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global minimally invasive surgical instruments market size is estimated to reach USD 51.49 billion by 2028, registering a CAGR of 14.5% over the forecast period, according to the report.

The cost of these instruments is significantly lower than in-patient and open surgeries. Thus, it is beneficial for patients and payers as well. Factors, such as reduction in healing time, smaller incisions, reduced anastatic use, decreased hospital stays, and increased accuracy, have also improved product adoption by most surgeons across the globe. Furthermore, an increase in investments by several organizations and hospitals to improve healthcare infrastructure is expected to create opportunities for manufacturers. To deliver a high standard of medical care, surgical wards in newly built hospitals are expected to be equipped with advanced surgical equipment, which is likely to propel market growth over the forecast period.

According to a research article published in the medical journal, JAMA Surgery, in March 2015, the use of Minimally Invasive Surgeries (MIS) for routine operations of the colon, lungs, and appendix can result in the reduction of postoperative complications, thereby saving nearly USD 280 million to USD 340 million per year. Investments in MIS instruments are gradually rising in hospitals, thereby driving the market.

Collaborative strategies undertaken by leaders in the market and constant updates & launches of new products have improved the market. The market saw a dip during 2020 due to the COVID-19 pandemic. Reduction in elective and planned surgeries by nearly 50% has declined the market dramatically. In addition, restrictions on logistic movement, disturbed raw material supplies, and economic instability of hospitals led to a dip in the market. However, it is said to stabilize by early 2022.

Minimally Invasive Surgical Instruments Market Report Highlights

• The handheld instrument segment accounted for the largest revenue share in 2020 due to high demand on account of benefits, such as improved recovery time and reduced side effects
• The orthopedic application segment held the largest market share in 2020. However, the cosmetic application segment will register the fastest CAGR from 2021 to 2028
• The Ambulatory Surgery Centers (ASCs) segment is estimated to register the fastest CAGR from 2021 to 2028
• ASCs offer low-cost surgeries and provide greater flexibility of scheduling as compared to hospitals
• North America dominated the global in 2020 due to the high rate of unintentional injuries and increasing geriatric population

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Manufacturer outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Minimally Invasive surgical instruments Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases
3.4.1.2. Technological advancement in minimally invasive surgical instruments
3.4.1.3. Rising geriatric population
3.4.2. Market restraint analysis
3.4.2.1. Long waiting time for surgeries
3.4.2.2. Lack of skilled professionals
3.5. Minimally Invasive surgical instruments Market Analysis Tools
3.5.1. Industry Analysis - Porter's
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Minimally invasive surgical instruments market: Device Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Handheld Instruments
4.1.2. Inflation Devices
4.1.3. Cutter Instruments
4.1.4. Guiding Devices
4.1.5. Electrosurgical Devices
4.1.6. Auxiliary Devices
4.1.7. Monitoring & Visualization Devices
4.2. Minimally Invasive surgical instruments Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Minimally Invasive surgical instruments Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Handheld Instruments
4.5.1.1. Handheld Instruments based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Inflation Devices
4.5.2.1. Inflation Devices based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.3. Cutter Instruments
4.5.3.1. Cutter Instruments based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.4. Guiding Devices
4.5.4.1. Guiding Devices based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.5. Electrosurgical Instruments
4.5.5.1. Electrosurgical Instruments based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.6. Auxiliary Devices
4.5.6.1. Auxiliary Devices based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.7. Monitoring and Visualization Devices
4.5.7.1. Monitoring and Visualization Devices based Market estimates and forecast 2016 to 2028 (USD Million)

Chapter 5. Minimally invasive surgical instruments market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Cardiac
5.1.2. Gastrointestinal
5.1.3. Orthopedic
5.1.4. Vascular
5.1.5. Gynecological
5.1.6. Urological
5.1.7. Thoracic
5.1.8. Cosmetic
5.1.9. Dental
5.1.10. Others
5.2. Minimally Invasive surgical instruments Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Minimally Invasive surgical instruments Market by application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Cardiac
5.5.1.1. Cardiac Market estimates and forecast 2016 to 2028 (USD Million)
5.5.2. Gastrointestinal
5.5.2.1. Gastrointestinal preparations Market estimates and forecast 2016 to 2028 (USD Million)
5.5.3. Orthopedic
5.5.3.1. Orthopedic Market estimates and forecast 2016 to 2028 (USD Million)
5.5.4. Vascular
5.5.4.1. Vascular Market estimates and forecast 2016 to 2028 (USD Million)
5.5.5. Gynecological
5.5.5.1. Gynecological Market estimates and forecast 2016 to 2028 (USD Million)
5.5.6. Urological
5.5.6.1. Urological Market estimates and forecast 2016 to 2028 (USD Million)
5.5.7. Thoracic
5.5.7.1. Thoracic Market estimates and forecast 2016 to 2028 (USD Million)
5.5.8. Cosmetic
5.5.8.1. Cosmetic Market estimates and forecast 2016 to 2028 (USD Million)
5.5.9. Dental
5.5.9.1. Dental Market estimates and forecast 2016 to 2028 (USD Million)
5.5.10. Others
5.5.10.1. Others Market estimates and forecast 2016 to 2028 (USD Million)

Chapter 6. Minimally invasive surgical instruments market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals & Clinics
6.1.2. Ambulatory Surgery center
6.2. S Minimally Invasive surgical instruments Market Share, 2021 & 2028
6.3. Segment Dashboard
6.4. Global Minimally Invasive surgical instruments Market by manufacturer Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.5.1. Hospital and Clinics
6.5.1.1. Hospitals and clinics market estimates and forecast 2016 to 2028 (USD Million)
6.5.2. Ambulatory Surgery Center
6.5.2.1. Ambulatory Surgery center market estimates and forecast 2016 to 2028 (USD Million)

Chapter 7. Minimally Invasive surgical instruments Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.3.4. Medtronic
8.3.4.1. Company Overview
8.3.4.2. Financial performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Siemens Healthineer AG
8.3.5.1. Company Overview
8.3.5.2. Financial performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Ethicon, Inc. (Johnson & Johnson)
8.3.6.1. Company Overview
8.3.6.2. Financial performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Depuy Synthes
8.3.7.1. Company Overview
8.3.7.2. Financial performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. GE Healthcare
8.3.8.1. Company Overview
8.3.8.2. Financial performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Abbott Laboratories
8.3.9.1. Company Overview
8.3.9.2. Financial performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Intutive Surgical, Inc.
8.3.10.1. Company Overview
8.3.10.2. Financial performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Nuvasive, Inc.
8.3.11.1. Company Overview
8.3.11.2. Financial performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Zimmer Biomet
8.3.12.1. Company Overview
8.3.12.2. Financial performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/3bn4ld

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets